Evidence map›Paper›PMID 29706618›Full record

ArticleCell death & disease2018

ECD promotes gastric cancer metastasis by blocking E3 ligase ZFP91-mediated hnRNP F ubiquitination and degradation.

Song-Hui Xu, Song Zhu, Yanjie Wang, Jin-Zhou Huang, Min Chen, Qing-Xia Wu, Yu-Tian He, De Chen, Guang-Rong Yan

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Song-Hui XuBiomedicine Research Center, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510150, China.
Song ZhuBiomedicine Research Center, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510150, China.
Yanjie WangBiomedicine Research Center, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510150, China.
Jin-Zhou HuangBiomedicine Research Center, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510150, China.
Min ChenBiomedicine Research Center, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510150, China.
Qing-Xia WuBiomedicine Research Center, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510150, China.
Yu-Tian HeBiomedicine Research Center, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510150, China.
De ChenBiomedicine Research Center, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510150, China. drchende@gzhmu.edu.cn.
Guang-Rong YanBiomedicine Research Center, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510150, China. jxygr007@yahoo.com.
Guangzhou Medical University · CNThird Affiliated Hospital of Guangzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human ortholog of the Drosophila ecdysoneless gene (ECD) is required for embryonic development and cell-cycle progression; however, its role in cancer progression and metastasis remains unclear. Here, we found that ECD is frequently overexpressed in gastric cancer (GC), especially in metastatic GC, and is correlated with poor clinical outcomes in GC patients. Silencing ECD inhibited GC migration and invasion in vitro and metastasis in vivo, while ECD overexpression promoted GC migration and invasion. ECD promoted GC invasion and metastasis by protecting hnRNP F from ubiquitination and degradation. We identified ZFP91 as the E3 ubiquitin ligase that is responsible for hnRNP F ubiquitination at Lys 185 and proteasomal degradation. ECD competitively bound to hnRNP F via the N-terminal STG1 domain (13-383aa), preventing hnRNP F from interacting with ZFP91, thus preventing ZFP91-mediated hnRNP F ubiquitination and proteasomal degradation. Collectively, our findings indicate that ECD promotes cancer invasion and metastasis by preventing E3 ligase ZFP91-mediated hnRNP F ubiquitination and degradation, suggesting that ECD may be a marker for poor prognosis and a potential therapeutic target for GC patients.

Indexed as

Cell MovementUbiquitinationAnimalsCarrier ProteinsFemaleGene Expression Regulation, EnzymologicGene Expression Regulation, NeoplasticHeLa CellsHeterogeneous-Nuclear Ribonucleoprotein Group F-HHumansMaleMice, Inbred NODMice, SCIDMiddle AgedNeoplasm InvasivenessNeoplasm MetastasisCarrier ProteinsECD protein, humanHeterogeneous-Nuclear Ribonucleoprotein Group F-HHNRNPF protein, humanUbiquitin-Protein LigasesZFP91 protein, human

Identifiers

PMID29706618
PMCPMC5924763
OpenAlexW2802372241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.